.
  • NIFTY 24,712.05 -255.70 (-1.02%)
  • SENSEX 80,786.54 -849.37 (-1.04%)
BSE
NSE

Tuesday, August 26, 2025 , BSE Sensex : 80,786.54 80,786.54(-1.04%) , Adani Ports : 1,315.50 1,315.50(-1.85%) , Asian Paints : 2,487.45 2,487.45(-0.21%) , Axis Bank : 1,050.15 1,050.15(-1.86%) , Bajaj Finance : 876.50 876.50(-2.67%) , Bajaj Finserv : 1,924.20 1,924.20(-2.00%) , Bharat Electron : 365.85 365.85(-1.65%) , Bharti Airtel : 1,905.40 1,905.40(-1.31%) , Eternal Ltd : 317.80 317.80(-0.49%) , HCL Technologies : 1,492.25 1,492.25(-0.82%) , HDFC Bank : 973.05 973.05(-0.94%) , Hind. Unilever : 2,692.10 2,692.10(2.38%) , ICICI Bank : 1,416.70 1,416.70(-1.15%) , Infosys : 1,529.85 1,529.85(-0.18%) , ITC : 403.10 403.10(0.93%) , Kotak Mah. Bank : 1,965.30 1,965.30(-0.92%) , Larsen & Toubro : 3,539.60 3,539.60(-1.76%) , M & M : 3,330.90 3,330.90(-2.02%) , Maruti Suzuki : 14,711.30 14,711.30(1.75%) , NTPC : 333.25 333.25(-1.36%) , Power Grid Corpn : 279.80 279.80(-1.53%) , Reliance Industr : 1,385.30 1,385.30(-1.95%) , SBI : 807.80 807.80(-0.94%) , Sun Pharma.Inds. : 1,600.45 1,600.45(-3.40%) , Tata Motors : 681.55 681.55(-0.75%) , Tata Steel : 155.00 155.00(-2.88%) , TCS : 3,156.25 3,156.25(0.49%) , Tech Mahindra : 1,502.20 1,502.20(-1.61%) , Titan Company : 3,592.90 3,592.90(-1.62%) , Trent : 5,292.60 5,292.60(-2.45%) , UltraTech Cem. : 12,608.35 12,608.35(0.03%) ,

Nifty 50 : 24,712.05 -255.70(-1.02%) , Adani Enterp. : 2,272.00 -30.90(-1.34%) , Adani Ports : 1,315.40 -25.00(-1.87%) , Apollo Hospitals : 7,793.50 -57.50(-0.73%) , Asian Paints : 2,481.40 -11.50(-0.46%) , Axis Bank : 1,050.10 -19.90(-1.86%) , Bajaj Auto : 8,691.50 -59.00(-0.67%) , Bajaj Finance : 876.25 -24.55(-2.73%) , Bajaj Finserv : 1,924.20 -39.60(-2.02%) , Bharat Electron : 365.85 -6.20(-1.67%) , Bharti Airtel : 1,904.70 -26.00(-1.35%) , Cipla : 1,579.80 -21.40(-1.34%) , Coal India : 372.45 -7.55(-1.99%) , Dr Reddy's Labs : 1,263.20 -20.70(-1.61%) , Eicher Motors : 6,151.00 160.50(2.68%) , Eternal Ltd : 317.90 -1.35(-0.42%) , Grasim Inds : 2,796.20 -15.20(-0.54%) , HCL Technologies : 1,492.80 -11.40(-0.76%) , HDFC Bank : 973.40 -8.65(-0.88%) , HDFC Life Insur. : 776.60 -10.40(-1.32%) , Hero Motocorp : 5,073.40 9.60(0.19%) , Hind. Unilever : 2,692.60 61.00(2.32%) , Hindalco Inds. : 705.70 -10.15(-1.42%) , ICICI Bank : 1,416.60 -16.60(-1.16%) , IndusInd Bank : 756.40 -14.45(-1.87%) , Infosys : 1,529.60 -2.50(-0.16%) , ITC : 403.35 4.00(1.00%) , Jio Financial : 315.75 -3.95(-1.24%) , JSW Steel : 1,047.10 -10.70(-1.01%) , Kotak Mah. Bank : 1,965.70 -17.60(-0.89%) , Larsen & Toubro : 3,541.30 -61.80(-1.72%) , M & M : 3,330.80 -68.10(-2.00%) , Maruti Suzuki : 14,714.00 262.00(1.81%) , Nestle India : 1,162.20 9.20(0.80%) , NTPC : 333.20 -4.65(-1.38%) , O N G C : 234.19 -2.57(-1.09%) , Power Grid Corpn : 279.90 -4.25(-1.50%) , Reliance Industr : 1,384.90 -27.70(-1.96%) , SBI : 807.85 -8.60(-1.05%) , SBI Life Insuran : 1,816.60 -30.20(-1.64%) , Shriram Finance : 594.70 -26.15(-4.21%) , Sun Pharma.Inds. : 1,600.30 -56.40(-3.40%) , Tata Consumer : 1,079.90 -1.70(-0.16%) , Tata Motors : 681.65 -5.15(-0.75%) , Tata Steel : 155.03 -4.60(-2.88%) , TCS : 3,157.20 16.60(0.53%) , Tech Mahindra : 1,502.20 -24.90(-1.63%) , Titan Company : 3,594.00 -57.40(-1.57%) , Trent : 5,295.00 -128.00(-2.36%) , UltraTech Cem. : 12,610.00 4.00(0.03%) , Wipro : 252.03 -1.81(-0.71%) , Tuesday, August 26, 2025

Home >> Markets >> Equities >> News - News Details
Hot Pursuit
26-Aug-2025     10:54
Aurobindo Pharma's arm gets UK MHRA nod for trastuzumab biosimilar dazublys

Earlier in July 2025, Dazublys was also granted marketing authorisation by the European Commission (EC) for use in the European Union. This marks CuraTeQ's fourth biosimilar approval from the MHRA, following the approvals of Bevqolva in December 2024, Zefylti in May 2025, and Dyrupeg in June 2025.

Notably, Dazublys, Zefylti, and Dyrupeg have also been approved in the European Union, further establishing CuraTeQ's growing footprint in regulated international markets and strengthening its biosimilars portfolio, it added.

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.

The company's consolidated net profit tumbled 10.3% to Rs 824.75 crore despite of 4.5% increase in revenue from operations to Rs 7791.77 crore in Q1 FY26 over Q1 FY25.

Shares of Aurobindo Pharma declined 1.63% to currently trade at Rs 1,050 on the BSE.

Powered by Capital Market - Live News